These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Performance of risk scores in predicting mortality at 3, 6, and 12 months in patients diagnosed with community-acquired pneumonia. Tuta-Quintero E; Bastidas AR; Guerrón-Gómez G; Perna-Reyes I; Torres D; Garcia L; Villanueva J; Acuña C; Mikler E; Arcila J; Chavez N; Riviera A; Maldonado V; Galindo M; Fernández M; Schloss C; Reyes LF BMC Pulm Med; 2024 Jul; 24(1):334. PubMed ID: 38987754 [TBL] [Abstract][Full Text] [Related]
43. Plasma kallistatin levels in patients with severe community-acquired pneumonia. Lin WC; Lu SL; Lin CF; Chen CW; Chao L; Chao J; Lin YS Crit Care; 2013 Feb; 17(1):R27. PubMed ID: 23394256 [TBL] [Abstract][Full Text] [Related]
44. Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study. Feng CM; Wang XM; Li MD; Xu Z; Hua DX; Cheng JY; Zheng L; Zhao H; Fu L BMC Pulm Med; 2021 Dec; 21(1):393. PubMed ID: 34856971 [TBL] [Abstract][Full Text] [Related]
45. Prognostic Value of Histidine-Rich Glycoprotein for Community-Acquired Pneumonia. He X; Luo Q; Zhao L; Shang Y; Gao Z Dis Markers; 2022; 2022():4713045. PubMed ID: 35154511 [TBL] [Abstract][Full Text] [Related]
46. Predicting Mortality and Use of RISC Scoring System in Hospitalized Under-Five Children Due to WHO Defined Severe Community Acquired Pneumonia. Kapoor A; Awasthi S; Kumar Yadav K J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35727140 [TBL] [Abstract][Full Text] [Related]
47. Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia. Falcone M; Corrao S; Venditti M; Serra P; Licata G Intern Emerg Med; 2011 Oct; 6(5):431-6. PubMed ID: 21249471 [TBL] [Abstract][Full Text] [Related]
48. Prognostic value of serum pregnancy-associated plasma protein A level at the initial ED presentation in elderly patients with CAP. Golcuk Y; Golcuk B; Bilge A; Korkmaz A; Irik M; Hayran M; Ozdemir AT; Kurtulmus Y Am J Emerg Med; 2015 Sep; 33(9):1232-6. PubMed ID: 26113245 [TBL] [Abstract][Full Text] [Related]
49. Scored minor criteria for severe community-acquired pneumonia predicted better. Guo Q; Song WD; Li HY; Zhou YP; Li M; Chen XK; Liu H; Peng HL; Yu HQ; Chen X; Liu N; Lü ZD; Liang LH; Zhao QZ; Jiang M Respir Res; 2019 Jan; 20(1):22. PubMed ID: 30704469 [TBL] [Abstract][Full Text] [Related]
50. Association of adrenal function and disease severity in community-acquired pneumonia. Mueller C; Blum CA; Trummler M; Stolz D; Bingisser R; Mueller C; Tamm M; Mueller B; Schuetz P; Christ-Crain M PLoS One; 2014; 9(6):e99518. PubMed ID: 24910975 [TBL] [Abstract][Full Text] [Related]
51. Prognostic Value of Plasma Presepsin and Pneumonia Severity Index in Patients with Community-Acquired Pneumonia in the Emergency Department. Lee KR; Hong DY; Paik JH; Jung HM Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363461 [TBL] [Abstract][Full Text] [Related]
53. Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Valencia M; Badia JR; Cavalcanti M; Ferrer M; Agustí C; Angrill J; García E; Mensa J; Niederman MS; Torres A Chest; 2007 Aug; 132(2):515-22. PubMed ID: 17505026 [TBL] [Abstract][Full Text] [Related]
54. Efficacy of the quick sequential organ failure assessment for predicting clinical outcomes among community-acquired pneumonia patients presenting in the emergency department. Zhang X; Liu B; Liu Y; Ma L; Zeng H BMC Infect Dis; 2020 Apr; 20(1):316. PubMed ID: 32349682 [TBL] [Abstract][Full Text] [Related]
55. Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia. Schuetz P; Stolz D; Mueller B; Morgenthaler NG; Struck J; Mueller C; Bingisser R; Tamm M; Christ-Crain M BMC Infect Dis; 2008 Feb; 8():22. PubMed ID: 18304365 [TBL] [Abstract][Full Text] [Related]
56. Prognostic factors in patients hospitalized with community-acquired aspiration pneumonia. Seo H; Cha SI; Lee WK; Park JE; Choi SH; Lee YH; Yoo SS; Lee SY; Lee J; Kim CH; Park JY J Infect Chemother; 2022 Jan; 28(1):47-53. PubMed ID: 34627705 [TBL] [Abstract][Full Text] [Related]
57. Multimarker Prognostication for Hospitalized Patients with Community-acquired Pneumonia. Yeon Lee S; Cha SI; Seo H; Oh S; Choi KJ; Yoo SS; Lee J; Lee SY; Kim CH; Park JY Intern Med; 2016; 55(8):887-93. PubMed ID: 27086800 [TBL] [Abstract][Full Text] [Related]
58. Metabolic profiles in community-acquired pneumonia: developing assessment tools for disease severity. Ning P; Zheng Y; Luo Q; Liu X; Kang Y; Zhang Y; Zhang R; Xu Y; Yang D; Xi W; Wang K; Chen Y; An S; Gao Z Crit Care; 2018 May; 22(1):130. PubMed ID: 29759075 [TBL] [Abstract][Full Text] [Related]
59. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia. Ugajin M; Yamaki K; Hirasawa N; Yagi T Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911 [TBL] [Abstract][Full Text] [Related]
60. Validation of a clinical prediction model for early admission to the intensive care unit of patients with pneumonia. Labarère J; Schuetz P; Renaud B; Claessens YE; Albrich W; Mueller B Acad Emerg Med; 2012 Sep; 19(9):993-1003. PubMed ID: 22978725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]